SPY396.92+7.29 1.87%
DIA318.84+6.42 2.05%
IXIC11,535.28+180.66 1.59%

BRIEF-Abbvie Reports Qtrly Net Revenue $13.54 Billion, Up 4.1% on GAAP basis

reuters.com · 04/29/2022 07:43
BRIEF-Abbvie Reports Qtrly Net Revenue $13.54 Billion, Up 4.1% on GAAP basis

- Abbvie Inc ABBV:

  • ABBVIE QTRLY NET REVENUE $13.54 BILLION, UP 4.1% ON A GAAP BASIS, OR 5.4% ON OPERATIONAL BASIS

  • Q1 EARNINGS PER SHARE VIEW $3.14, REVENUE VIEW $13.61 BILLION -- REFINITIV IBES DATA

  • ABBVIE QTRLY GAAP EARNINGS PER SHARE $2.51; QTRLY ADJUSTED EARNINGS PER SHARE $3.16

  • ABBVIE - IN U.S., QTRLY HUMIRA NET REVENUE OF $3.993 BILLION, UP 2.2%

  • ABBVIE - INTERNATIONALLY, QTRLY HUMIRA NET REVENUE OF $743 MILLION, DOWN 22.6% ON REPORTED BASIS, OR 17.9% ON OPERATIONAL BASIS, DUE TO BIOSIMILAR COMPETITION

  • ABBVIE - QTRLY GLOBAL IMBRUVICA NET REVENUE $1.173 BILLION, DOWN 7.4%; QTRLY GLOBAL BOTOX COSMETIC NET REVENUE $641 MILLION, UP 34.4% ON REPORTED BASIS

  • ABBVIE - QTRLY GLOBAL HUMIRA NET REVENUE OF $4.736 BILLION, DOWN 2.7% ON REPORTED BASIS, OR 1.8% ON OPERATIONAL BASIS

  • ABBVIE - UPDATES 2022 ADJUSTED DILUTED EPS GUIDANCE RANGE FROM $14.00-$14.20 TO $13.92-$14.12

  • FY2022 EARNINGS PER SHARE VIEW $14.11 -- REFINITIV IBES DATA

Further company coverage: ABBV


((Reuters.Briefs@thomsonreuters.com;))